IDNAvsSPMD
iShares Genomics Immunology and Healthcare ETF against SPDR Portfolio S&P 400 Mid Cap ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDNA | SPMD | |
|---|---|---|
| Expense ratio | 0.47% | 0.030% |
| Assets | $299M | $18.1B |
| Net flow, 1 month | +$29M | +$190M |
| Net flow, 1 year | +$83M | +$2.1B |
| Return, YTD | +59.0% | +11.0% |
| Return, 1 year | +69.0% | +11.6% |
| Avg daily volume | 189K | 1.6M |
| Holdings | 63 | 401 |
| Listed | Jun 11, 2019 | Nov 8, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS